Lortab 10-325 mg (g037 pill) is categorized as a Scheduled II controlled substance by the CSA (Controlled Substance Act). It has a high potential for abuse and dependency. The white oval g037 pill is comprised of two chemical elements Hydrocodone and Acetaminophen. Both these components work together to treat moderate to severe pain in patients.

g037 white oval pill used for activating opioid receptors as a narcotic drug in the central nervous system of the brain. It inhibited the pain signal between the body and the brain. Hydrocodone in 7.5 mg and acetaminophen in 325 mg dosage strengths act as generic and active ingredients in the branded Lortab 10-325 mg.

The classification of this drug was done through the Controlled Substance Act (CSA) under Scheduled II controlled substance. Lortab had a risk of addiction and abuse. Lortab g037 white oblong is administered orally.

Function of Lortab 10-325 mg Medicine

Acetaminophen is a less potent non-opioid analgesic that helps to enhance the effect of hydrocodone. Due to the agonist properties of hydrocodone, it activates and binds the mu, delta, and kappa receptors. These are coupled with G-protein (inhibitory) which inhibits the pain signals.

Side Effects of Lortab 10-325 mg Drug

Depression, dysphoria (feeling of unhappiness), ureteral cramping, confusion, upset stomach, weight loss, itching (pruritus), hallucination (seeing things or objects that are not real), trouble breathing, etc.

Note On g037 Pill:

The Food and Drug Administration (FDA) discontinued the Lortab branded drug. However, the U.S. FDA approves generic versions of Lortab 10-325 mg (Food and Drug Administration).